Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Controlled Substances and the Pharmacist - Webinar By GlobalCompliancePanel

15 February 2011, Wilmington, United States


Introduction
The public media has been reporting the abuse of narcotic drugs prescribed for pain management with its focus on the legitimacy of prescriptions and the dispensing by a pharmacist. Both federal and state regulations have placed the responsibilities on the physician who wrote the prescription and the pharmacist who filled the prescription.

Today's pharmacists will need to familiarize themselves with the stringent laws and regulations enforced by the Drug Enforcement Administration (DEA) through their Office of Diversion Control (Diversion). Since the focus of any DEA investigation is the legitimacy of a prescription, the initial target is the pharmacist who fulfilled the prescription. The pharmacy may be inspected in order to determine their handling of controlled substances purchased and dispensed as a prescription. The inspection targets record-keeping requirements, security of all controlled substances, and review of dispensed prescriptions.

Class participants will familiarize themselves with federal laws and DEA regulations requirements for handling of Schedules II though V controlled substances in a pharmacy setting and the record-keeping and security responsibilities placed on the pharmacist.
Venue
Online Training Webinar

Online Training Webinar, 1000 N West Street | Suite 1200, Wilmington, 19801, United States

Organised by
GlobalCompliancePanel
Contact information
Webinars
1000 N West Street | Suite 1200, Wilmington, 19801, United States of America
800-447-9407
Contact us by email

Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*